{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:20:05Z","timestamp":1790266805933,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T00:00:00Z","timestamp":1632355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T00:00:00Z","timestamp":1632355200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Med Ther"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Vulvovaginal candidiasis (VVC), the second leading cause of genital infection in women of reproductive age, is caused by yeasts of the genus\n                      <jats:italic>Candida.<\/jats:italic>\n                      Treatment is usually empirical and performed with azoles, which have shown increasing ineffectiveness due to resistance from these species. This therapeutic challenge has led to the search for new treatment strategies.\n                      <jats:italic>Lactobacillus<\/jats:italic>\n                      spp. produce several components with microbicidal effects, such as lactic acid. These species are the main components of a healthy vaginal microbiota and have been used as probiotics. The aim of this work was to investigate the in vitro inhibitory effects of\n                      <jats:italic>Lactobacillus casei<\/jats:italic>\n                      Shirota on both the\n                      <jats:italic>Candida<\/jats:italic>\n                      spp. that cause VVC and on\n                      <jats:italic>C. auris<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      The microbicidal effects of\n                      <jats:italic>L. casei<\/jats:italic>\n                      Shirota on the main VVC-causing species,\n                      <jats:italic>C. albicans<\/jats:italic>\n                      ,\n                      <jats:italic>C. tropicalis<\/jats:italic>\n                      ,\n                      <jats:italic>C. norvegensis<\/jats:italic>\n                      and\n                      <jats:italic>C. parapsilosis,<\/jats:italic>\n                      in addition to\n                      <jats:italic>C. auris<\/jats:italic>\n                      were investigated by counting the Colony-forming Units (CFUs) after cocultivation. The antifungal activity of lactic acid against these\n                      <jats:italic>Candida<\/jats:italic>\n                      strains was assessed using the microtiter broth dilution method to determine the minimum inhibitory concentrations (MICs). The effects of\n                      <jats:italic>L. casei<\/jats:italic>\n                      Shirota on hyphal and early biofilm formation was measured by optical microscopy.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      <jats:italic>L. casei<\/jats:italic>\n                      Shirota showed inhibitory action against all tested\n                      <jats:italic>Candida<\/jats:italic>\n                      spp., ranging from 66.9 to 95.6% inhibition depending on the species. This inhibition is possibly related to the production of lactic acid, since lactic acid has shown microbicidal action against these same\n                      <jats:italic>Candida<\/jats:italic>\n                      spp. at a concentration of 5\u2009mg\/mL, which corresponds to half of the normal physiological concentration. In addition,\n                      <jats:italic>L. casei<\/jats:italic>\n                      Shirota was able to reduce the formation of\n                      <jats:italic>C. albicans<\/jats:italic>\n                      hyphae and early biofilms, showing strong anti-\n                      <jats:italic>Candida<\/jats:italic>\n                      effects.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      These results suggest that\n                      <jats:italic>L. casei<\/jats:italic>\n                      Shirota has antifungal activity against the\n                      <jats:italic>Candida<\/jats:italic>\n                      species that cause VVC.\n                      <jats:italic>L. casei<\/jats:italic>\n                      also has microbicidal action against\n                      <jats:italic>C. auris<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12906-021-03405-z","type":"journal-article","created":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T13:04:58Z","timestamp":1632402298000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Inhibitory effects of Lactobacillus casei Shirota against both Candida auris and Candida spp. isolates that cause vulvovaginal candidiasis and are resistant to antifungals"],"prefix":"10.1186","volume":"21","author":[{"given":"Aline Lorenzoni","family":"Pani\u00e1gua","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amabel Fernandes","family":"Correia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00edvia Cust\u00f3dio","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruna Maciel","family":"de Alencar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana Brand\u00e3o Alves","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4179-8533","authenticated-orcid":false,"given":"Rosane Mansan","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanna Karla","family":"de Medeiros N\u00f3brega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,23]]},"reference":[{"key":"3405_CR1","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.colsurfb.2018.11.011","volume":"174","author":"C Rodr\u00edguez-Cerdeira","year":"2019","unstructured":"Rodr\u00edguez-Cerdeira C, Gregorio MC, Molares-Vila A, L\u00f3pez-Barcenas A, Fabbrocini G, Bardhi B, et al. Biofilms and vulvovaginal candidiasis. Colloids Surf B Biointerfaces. 2019;174:110\u201325. https:\/\/doi.org\/10.1016\/j.colsurfb.2018.11.011.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"3405_CR2","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12905-019-0748-8","volume":"19","author":"J Yano","year":"2019","unstructured":"Yano J, Sobel JD, Nyirjesy P, Sobel R, Williams VL, Yu Q, et al. Current patient perspectives of vulvovaginal candidiasis: incidence, symptoms, management and post-treatment outcomes. BMC Womens Health. 2019;19:48. https:\/\/doi.org\/10.1186\/s12905-019-0748-8.","journal-title":"BMC Womens Health"},{"issue":"6","key":"3405_CR3","doi-asserted-by":"publisher","first-page":"905","DOI":"10.3109\/1040841X.2015.1091805","volume":"42","author":"B Gon\u00e7alves","year":"2016","unstructured":"Gon\u00e7alves B, Ferreira C, Alves CT, Henriques M, Azeredo J, Silva S. Vulvovaginal candidiasis: epidemiology, microbiology and risk factors. Crit Rev Microbiol. 2016;42(6):905\u201327. https:\/\/doi.org\/10.3109\/1040841X.2015.1091805.","journal-title":"Crit Rev Microbiol"},{"key":"3405_CR4","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/615958","volume-title":"Non-C. albicans Candida infection: an emerging threat","author":"SC Deorukhkar","year":"2014","unstructured":"Deorukhkar SC, Saini S, Mathew S. Non-C. albicans Candida infection: an emerging threat; 2014. https:\/\/doi.org\/10.1155\/2014\/615958."},{"issue":"4","key":"3405_CR5","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3390\/jof4040121","volume":"4","author":"O Makanjuola","year":"2018","unstructured":"Makanjuola O, Bongomin F, Fayemiwo SA. An update on the roles of Non-C. albicans Candida species in vulvovaginitis. J Fungi (Basel). 2018;4(4):121. https:\/\/doi.org\/10.3390\/jof4040121.","journal-title":"J Fungi (Basel)"},{"issue":"1","key":"3405_CR6","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2174\/1567201813666160502125620","volume":"14","author":"A Behtash","year":"2017","unstructured":"Behtash A, Nafisi S, Maibach H. New generation of fluconazole: a review on existing researches and technologies. Curr Drug Deliv. 2017;14(1):2\u201315. https:\/\/doi.org\/10.2174\/1567201813666160502125620.","journal-title":"Curr Drug Deliv"},{"issue":"9","key":"3405_CR7","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1080\/14656566.2018.1476490","volume":"19","author":"JD Sobel","year":"2018","unstructured":"Sobel JD, Sobel R. Current treatment options for vulvovaginal candidiasis caused by azole-resistant Candida species. Expert Opin Pharmacother. 2018;19(9):971\u20137. https:\/\/doi.org\/10.1080\/14656566.2018.1476490.","journal-title":"Expert Opin Pharmacother"},{"key":"3405_CR8","doi-asserted-by":"publisher","unstructured":"Haegler P, Joerin L, Kr\u00e4henb\u00fchl S, Bouitbir J. Hepatocellular Toxicity of Imidazole and Triazole Antimycotic Agents. Toxicological Sciences. 2017;157(1):183\u201395. https:\/\/doi.org\/10.1093\/toxsci\/kfx029.","DOI":"10.1093\/toxsci\/kfx029"},{"key":"3405_CR9","doi-asserted-by":"publisher","unstructured":"Marx-Stoelting P, Constanze K, Braeuning A. The Connection of Azole Fungicides with Xeno-Sensing Nuclear Receptors Drug Metabolism and Hepatotoxicity. Cells. 2020;9(5):1192. https:\/\/doi.org\/10.3390\/cells9051192.","DOI":"10.3390\/cells9051192"},{"issue":"1","key":"3405_CR10","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/1423-0127-19-58","volume":"19","author":"D Wagner","year":"2012","unstructured":"Wagner D, Johnson SJ. Probiotic lactobacillus and estrogen effects on vaginal epithelial gene expression responses to Candida albicans. J Biomed Sci. 2012;19(1):58. https:\/\/doi.org\/10.1186\/1423-0127-19-58.","journal-title":"J Biomed Sci"},{"issue":"7","key":"3405_CR11","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1007\/s00784-018-2347-8","volume":"22","author":"MVP Le\u00e3o","year":"2018","unstructured":"Le\u00e3o MVP, Tavares TAA, Gon\u00e7alves e Silva CR, dos Santos SSF, Junqueira JC, de Oliveira LD, et al. Lactobacillus rhamnosus intake can prevent the development of Candidiasis. Clin Oral Investig. 2018;22(7):2511\u20138. https:\/\/doi.org\/10.1007\/s00784-018-2347-8.","journal-title":"Clin Oral Investig"},{"issue":"9","key":"3405_CR12","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1093\/cid\/ciw038","volume":"62","author":"VH Matsubara","year":"2016","unstructured":"Matsubara VH, Bandara HMHN, Mayer MPA, Samaranayake LP. Probiotics as antifungals in mucosal candidiasis. Clin Infect Dis. 2016;62(9):1143\u201353. https:\/\/doi.org\/10.1093\/cid\/ciw038.","journal-title":"Clin Infect Dis"},{"key":"3405_CR13","doi-asserted-by":"publisher","unstructured":"Kovachev S. Defence factors of vaginal lactobacilli. Crit Rev Microbiol. 2018;44(1):31\u20139. https:\/\/doi.org\/10.1080\/1040841X.2017.1306688.","DOI":"10.1080\/1040841X.2017.1306688"},{"issue":"9-10","key":"3405_CR14","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.resmic.2017.04.001","volume":"168","author":"G Tachedjian","year":"2017","unstructured":"Tachedjian G, Aldunate M, Bradshaw CS, Cone RA. The role of lactic acid production by probiotic Lactobacillus species in vaginal health. Res Microbiol. 2017;168(9-10):782\u201392. https:\/\/doi.org\/10.1016\/j.resmic.2017.04.001.","journal-title":"Res Microbiol"},{"key":"3405_CR15","doi-asserted-by":"publisher","unstructured":"Petrova MI, Lievens E, Shweta M, Imholz N, Lebeer S. Lactobacillus species as biomarkers and agents that can promote various aspects of vaginal health. Front Physiol. 2015;6. https:\/\/doi.org\/10.3389\/fphys.2015.00081.","DOI":"10.3389\/fphys.2015.00081"},{"key":"3405_CR16","doi-asserted-by":"publisher","unstructured":"Petrova MI, Gregor R, Vaneechoutte M, Lebeer S. Lactobacillus iners : Friend or Foe?. Trends Microbiol. 2017;25(3):182\u201391. https:\/\/doi.org\/10.1016\/j.tim.2016.11.007.","DOI":"10.1016\/j.tim.2016.11.007"},{"issue":"1","key":"3405_CR17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ajog.2015.06.067","volume":"214","author":"JD Sobel","year":"2016","unstructured":"Sobel JD. Recurrent vulvovaginal candidiasis. Am J Obstet Gynecol. 2016;214(1):15\u201321. https:\/\/doi.org\/10.1016\/j.ajog.2015.06.067.","journal-title":"Am J Obstet Gynecol"},{"key":"3405_CR18","doi-asserted-by":"publisher","unstructured":"Spivak ES, Hanson KE, Kraft CZ. Candida auris: an Emerging Fungal Pathogen. J Clin MicrobiolC. 2018;56(2). https:\/\/doi.org\/10.1128\/JCM.01588-17.","DOI":"10.1128\/JCM.01588-17"},{"key":"3405_CR19","doi-asserted-by":"publisher","unstructured":"Rossoni RD, de Barros PP, Mendon\u00e7a IDC, Medina RP, Silva DHS, Fuchs BB, Junqueira JC, Mylonakis E. The Postbiotic Activity of Lactobacillus paracasei 28.4 Against Candida auris. Front Cell Infect Microbiol. 2020;10. https:\/\/doi.org\/10.3389\/fcimb.2020.00397.","DOI":"10.3389\/fcimb.2020.00397"},{"key":"3405_CR20","volume-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard \u2014 second edition serving the world \u2019 s medical science community through voluntary consensus","author":"MA Pfaller","year":"2002","unstructured":"Pfaller MA, Haturvedi V, Espinel-Ingroff A, Ghannoum MA, Gosey LL, Odds FC, et al. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard \u2014 second edition serving the world \u2019 s medical science community through voluntary consensus. 2002."},{"key":"3405_CR21","doi-asserted-by":"publisher","unstructured":"Kang MS, Lim HS, Oh JS, Lim YJ, Wuertz-Kozak K, Harro JM, et al. Antimicrobial activity of Lactobacillus salivarius and Lactobacillus fermentum against Staphylococcus aureus. Pathog Dis. 2017;75(2). https:\/\/doi.org\/10.1093\/femspd\/ftx009.","DOI":"10.1093\/femspd\/ftx009"},{"issue":"4","key":"3405_CR22","doi-asserted-by":"publisher","first-page":"419","DOI":"10.4103\/0255-0857.142261","volume":"32","author":"SK Hong","year":"2014","unstructured":"Hong SK, Chang BK, Song SH, Kim EC. Use of MALDI-TOF MS technique for rapid identification of bacteria from positive blood cultures. Indian J Med Microbiol. 2014;32(4):419\u201322. https:\/\/doi.org\/10.4103\/0255-0857.142261.","journal-title":"Indian J Med Microbiol"},{"issue":"11","key":"3405_CR23","doi-asserted-by":"publisher","first-page":"e80074","DOI":"10.1371\/journal.pone.0080074","volume":"8","author":"DE O\u2019hanlon","year":"2013","unstructured":"O\u2019hanlon DE, Moench TR, Cone RA. Vaginal pH and microbicidal lactic acid when lactobacilli dominate the microbiota. PLoS One. 2013;8(11):e80074. https:\/\/doi.org\/10.1371\/journal.pone.0080074.","journal-title":"PLoS One"},{"issue":"1","key":"3405_CR24","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/jof5010021","volume":"5","author":"D Kornitzer","year":"2019","unstructured":"Kornitzer D. Regulation of Candida albicans hyphal morphogenesis by endogenous signals. J Fungi (Basel). 2019;5(1):21. https:\/\/doi.org\/10.3390\/jof5010021.","journal-title":"J Fungi (Basel)"},{"issue":"6","key":"3405_CR25","doi-asserted-by":"publisher","first-page":"e0197925","DOI":"10.1371\/journal.pone.0197925","volume":"13","author":"K Lagree","year":"2018","unstructured":"Lagree K, Mon HH, Mitchell AP, Ducker WA. Impact of surface topography on biofilm formation by Candida albicans. PLoS One. 2018;13(6):e0197925. https:\/\/doi.org\/10.1371\/journal.pone.0197925.","journal-title":"PLoS One"},{"issue":"3","key":"3405_CR26","doi-asserted-by":"publisher","first-page":"139","DOI":"10.6118\/jmm.2017.23.3.139","volume":"23","author":"J-M Kim","year":"2017","unstructured":"Kim J-M, Park YJ. Probiotics in the prevention and treatment of postmenopausal vaginal infections: review article. J Menopausal Med. 2017;23(3):139\u201345. https:\/\/doi.org\/10.6118\/jmm.2017.23.3.139.","journal-title":"J Menopausal Med"},{"issue":"6","key":"3405_CR27","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/aji.12232","volume":"71","author":"P Mirmonsef","year":"2014","unstructured":"Mirmonsef P, Spear GT. The barrier to HIV transmission provided by genital tract Lactobacillus colonization. Am J Reprod Immunol. 2014;71(6):531\u20136. https:\/\/doi.org\/10.1111\/aji.12232.","journal-title":"Am J Reprod Immunol"},{"issue":"5","key":"3405_CR28","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S0092-8674(00)80358-X","volume":"90","author":"HJ Lo","year":"1997","unstructured":"Lo HJ, K\u00f6hler JR, Didomenico B, Loebenberg D, Cacciapuoti A, Fink GR. Nonfilamentous C. albicans mutants are avirulent. Cell. 1997;90(5):939\u201349. https:\/\/doi.org\/10.1016\/S0092-8674(00)80358-X.","journal-title":"Cell"},{"key":"3405_CR29","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.chom.2019.02.008","volume":"25","author":"JN Witchley","year":"2019","unstructured":"Witchley JN, Penumetcha P, Abon NV, Woolford CA, Mitchell AP, Noble SM. Candida albicans morphogenesis programs control the balance between gut commensalism and invasive infection. Cell Host Microbe. 2019;25:432\u2013443.e6. https:\/\/doi.org\/10.1016\/j.chom.2019.02.008.","journal-title":"Cell Host Microbe"},{"issue":"4","key":"3405_CR30","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1128\/IAI.00001-10","volume":"78","author":"CGJ McKenzie","year":"2010","unstructured":"McKenzie CGJ, Koser U, Lewis LE, Bain JM, Mora-Montes HM, Barker RN, et al. Contribution of Candida albicans cell wall components to recognition by and escape from murine macrophages. Infect Immun. 2010;78(4):1650\u20138. https:\/\/doi.org\/10.1128\/IAI.00001-10.","journal-title":"Infect Immun"},{"issue":"1","key":"3405_CR31","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/nrmicro.2017.107","volume":"16","author":"MB Lohse","year":"2018","unstructured":"Lohse MB, Gulati M, Johnson AD, Nobile CJ. Development and regulation of single-and multi-species Candida albicans biofilms. Nat Rev Microbiol. 2018;16(1):19\u201331. https:\/\/doi.org\/10.1038\/nrmicro.2017.107.","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"3405_CR32","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1146\/annurev-micro-091014-104330","volume":"69","author":"CJ Nobile","year":"2015","unstructured":"Nobile CJ, Johnson AD. Candida albicans biofilms and human disease. Annu Rev Microbiol. 2015;69(1):71\u201392. https:\/\/doi.org\/10.1146\/annurev-micro-091014-104330.","journal-title":"Annu Rev Microbiol"},{"issue":"1","key":"3405_CR33","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/j.1749-6632.2011.06041.x","volume":"1230","author":"D Danielsson","year":"2011","unstructured":"Danielsson D, Teigen PK, Moi H. The genital econiche: focus on microbiota and bacterial vaginosis. Ann N Y Acad Sci. 2011;1230(1):48\u201358. https:\/\/doi.org\/10.1111\/j.1749-6632.2011.06041.x.","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"3405_CR34","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.intimp.2012.05.023","volume":"14","author":"HM Joo","year":"2012","unstructured":"Joo HM, Kim KA, Myoung KS, Ahn YT, Lee JH, Huh CS, et al. Lactobacillus helveticus HY7801 ameliorates vulvovaginal candidiasis in mice by inhibiting fungal growth and NF-\u03baB activation. Int Immunopharmacol. 2012;14(1):39\u201346. https:\/\/doi.org\/10.1016\/j.intimp.2012.05.023.","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"3405_CR35","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1093\/jac\/dkl246","volume":"58","author":"ME Falagas","year":"2006","unstructured":"Falagas ME, Betsi GI, Athanasiou S. Probiotics for prevention of recurrent vulvovaginal candidiasis: a review. J Antimicrob Chemother. 2006;58(2):266\u201372. https:\/\/doi.org\/10.1093\/jac\/dkl246.","journal-title":"J Antimicrob Chemother"}],"container-title":["BMC Complementary Medicine and Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-021-03405-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12906-021-03405-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-021-03405-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T13:05:15Z","timestamp":1632402315000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-021-03405-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,23]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["3405"],"URL":"https:\/\/doi.org\/10.1186\/s12906-021-03405-z","relation":{},"ISSN":["2662-7671"],"issn-type":[{"value":"2662-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,23]]},"assertion":[{"value":"22 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research was carried out in accordance with the principles of the Declaration of Helsinki and approved by the \u201cComit\u00ea de \u00c9tica em Pesquisa da Faculdade de Ci\u00eancias da Sa\u00fade da Universidade de Bras\u00edlia\u201d (Ethics Committee, CEP-FS) through consubstantiated opinion number 3,430,073. All participants signed an informed consent form.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"237"}}